Anand Rathi Recommends Buying Infosys; Sets Target Price at Rs 1884

• Infosys showed resilient performance in a seasonally softer quarter with 0.6% QoQ constant currency revenue growth.
• The company secured a large deal Total Contract Value (TCV) of $4.8 billion, a 92% YoY increase, including a significant ~$1.6 billion NHS deal.
• Management raised FY26 guidance to 3-3.5% and anticipates stronger growth in FY27, driven by increased discretionary spending and deal traction in FS and E&U sectors.
• Infosys is positioning itself as a leading GenAI-led transformation partner, leveraging its Cognition partnership, Topaz fabric, and ~4.6 thousand GenAI projects.
• Anand Rathi revised revenue and EPS estimates, arriving at a Target Price (TP) of Rs 1,884, suggesting a ~17.1% upside from the Current Market Price.

Why It Matters: Anand Rathi recommends buying Infosys, citing strong deal wins, improved guidance, and GenAI leadership, with a target of Rs 1884.